Jan. 11, 2017

Winship endorses updated HPV vaccine recommendations

Photo of Winship endorses updated HPV vaccine recommendations

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), Winship Cancer Institute of Emory University has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

The new guidelines from the CDC recommend that children aged 11 to 12 should receive two doses of the HPV vaccine at least six months apart. Adolescents and young adults older than 15 should continue to complete the three-dose series.

"HPV causes many cancers afflicting patients cared for at Winship Cancer Institute, especially cancers in the tongue and throat region," says Walter J. Curran, Jr., MD, Winship's executive director. "A fully executed HPV vaccination program would lessen the future burden of such cancers on the citizens of Georgia."

According to the CDC, incidence rates of HPV-associated cancers have continued to rise, with approximately 39,000 new HPV-associated cancers now diagnosed each year in the United States. Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers, vaccination rates remain low across the U.S., with just 41.9 percent of girls and 28.1 percent of boys completing the recommend vaccine series.

Research shows there are a number of barriers to overcome to improve vaccination rates, including a lack of strong recommendations from physicians and parents not understanding that this vaccine protects against several types of cancer.

In an effort to overcome these barriers, NCI-designated cancer centers have organized a continuing series of national summits to share new research, discuss best practices, and identify collective action toward improving vaccination rates.

The original joint statement, published in January 2016, was the major recommendation from a summit in November 2015, which brought together experts from the NCI, CDC, American Cancer Society and more than half of the NCI-designated cancer centers.

For more info, contact:

Cascade Link  TOP